Impact of the COVID-19 Pandemic on Cancer Patients: Challenges and Practical Approach to Management
Abstract
The coronavirus 2019 (COVID-19) outbreak has rapidly spread worldwide, which poses great challenges to the healthcare system around the world. This pandemic has shown that globally medical community has no care- models to deal with the effects imposed on patients with chronic illnesses. Appropriate and timely diagnosis and treatment of this highly vulnerable immunocompromised population is mandatory. Prominent challenges faced during the current outbreak include resource allocation, management of patients suffering from and follow-up-phases, patient fear and protection of healthcare workers. During Pandemic, the major management strategies for cancer patients comprise education about personal protective measures, symptoms of COVID- 19, emotional support, clear communication about infection control measures and clinical care. To decrease the risk of exposure, active individualized cancer intervention is required with reduce outpatient visits and maximum telemedicine. Currently, international guidelines to manage cancer patients in any infectious pandemic are not available. The development of a complete contingency plan with guidelines for the safety and patients care will pose beneficial effects by minimizing the risks of morbidity and mortality.
References
Ahmad A, Mueller C, Tsamakis K. Covid-19 pandemic: a public and global mental health opportunity for social transformation. Bmj. 2020; 369: 1383.
Docea AO, Tsatsakis A, Albulescu D, Cristea O, Zlatian O, Vinceti M, et al. A new threat from an old enemy: Re- emergence of coronavirus. Int. J. Mol. Med. 2020; 45: 1631- 43.
Constantinou C, Kolokotroni O, Mosquera MC, Heraclides A, Demetriou C, Karayiannis P, et al. Developing a holistic contingency plan: Challenges and dilemmas for cancer patients during the COVID-19. Cancer Med. 2020; 9: 6082-92.
Kamboj M, Sepkowitz KA. Nosocomial infections in patients with cancer. Lancet Oncol. 2009; 10: 589-97.
Schrag D, Hershman DL, Basch E. Oncology Practice during the COVID-19 pandemic. Jama. 2020; 323: 2005-6.
Galluzzi L, Buque A, Kepp O, Zitvogel L, Kroemer G. Immunological effects of conventional chemotherapy and targeted anticancer agents. Cancer cell. 2015; 28: 690-714.
Adashek JJ, Hajjar J, Chemaly RF, Kurzrock R. Are cancer patients at higher risk of death with COVID-19? NPJ Precis Oncol. 2020; 3: 49-51.
Al-Quteimat OM, Amer AM. The impact of the COVID-19 pandemic on cancer patients. Am. J. Clin. Oncol. 2020; 43:1.
Liang W, Guan W, Chen R, Wang W, Li J, Xu K, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020; 21: 335-7.
Moujaess E, Kourie HR, Ghosn M. Cancer patients and
research during COVID-19 pandemic: a systematic review of current evidence. Critical Reviews in Oncology/Hematology. 2020; 150: 102972.
Dignani MC, Costantini P, Salgueira C, Jordán R, Guerrini G, Valledor A, et al. Pandemic 2009 Influenza A (H1N1) virus infection in cancer and hematopoietic stem cell transplant recipients; a multicenter observational study. F1000Research. 2014; 3: 221.
Yu J, Ouyang W, Chua ML, Xie C. SARS-CoV-2 transmission in cancer patients of a tertiary hospital in Wuhan. medRxiv. 2020; 6: 1108–10.
Zhonghua Liu Xing Bing Xue Za Zhi. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Novel CPERE. 2020; 41: 145- 151.
Onder G, Rezza G, Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. Jama. 2020; 323: 1775-6.
Zhang L, Zhu F, Xie L, Wang C, Wang J, Chen R, et al. Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China. Annals of Oncology. 2020; 31: 894-901.
Kuderer NM, Choueiri TK, Shah DP, Shyr Y, Rubinstein SM, Rivera DR, et al. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. The Lancet. 2020; 395: 1907-18.
Lee LY, Cazier JB, Starkey T, Turnbull C, Team UCCMP, Kerr R, et al. COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study. The Lancet. 2020; 395: 1919-26.
Dai M, Liu D, Liu M, Zhou F, Li G, Chen Z, et al. Patients with cancer appears more vulnerable to SARS-COV-2: a multicenter study during the COVID-19 outbreak. Cancer discovery. 2020; 10: 783-91.
Robilotti EV, Babady NE, Mead PA, Rolling T, Perez-Johnston R, Bernardes M, et al. Determinants of COVID-19 disease severity in patients with cancer. Nature medicine. 2020; 26: 1218-23.
He W, Chen L, Chen L, Yuan G, Fang Y, Chen W, et al. COVID- 19 in persons with haematological cancers. Leukemia. 2020; 24: 1-9.
Cook G, Ashcroft AJ, Pratt G, Popat R, Ramasamy K, Kaiser M, et al. Real-world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID-19 disease) in patients with Multiple Myeloma receiving systemic anti-cancer therapy. British Journal of Haematology. 2020; 190: 83-6.
Luo J, Rizvi H, Preeshagul IR, Egger JV, Hoyos D, Bandlamudi C, et al. COVID-19 in patients with lung cancer. Ann Oncol. 2020; 31: 1386–96.
Willan J, King AJ, Djebbari F, Turner GD, Royston DJ, Pavord S, et al. Assessing the Impact of Lockdown: Fresh Challenges for the Care of Haematology Patients in the COVID-19 Pandemic. Br. J. Haematol. 2020; 189: 224-7.
The Cancer Letter. What to expect: Oncology's response to coronavirus in Italy: “It's like being in a war”. Available at https://cancerletter.Com/articles/20200311_1/. [Accessed on August 13, 2020].
Hospitals are canceling elective surgeries to make space for a potential flood of coronavirus patients. Available at https://www.cnbc.com/2020/ 03/13/hospitals-cancel- elective-surgery-to-make-ro om-for-coronavirus- influx.html. [Accessed on August 20, 2020].
Battershill PM. Influenza pandemic planning for cancer patients. Current Oncology. 2006; 13: 119-20.
Alpert A, Jacobson M. Impact of oncology drug shortages on chemotherapy treatment. Clinical Pharmacology & Therapeutics. 2019; 106: 415-21.
U.S. Food & Drug Administration .FDA drug shortages. Available at https://www.accessdata.fda.gov/ scripts/drugshortages/default.cfm. [Accessed on July 21, 2020].
Xia Y, Jin R, Zhao J, Li W, Shen H. Risk of COVID-19 for cancer patients. Lancet Oncol. 2020; 21: 181.
Pellino G, Spinelli A. How Coronavirus Disease 2019 Outbreak Is Impacting Colorectal Cancer Patients in Italy: A Long Shadow Beyond Infection. Diseases of the Colon & Rectum. 2020; 63: 720-2.
National Comprehensive Cancer Network (NCCN): NCCN Best Practices Committee Infusion Efficiency Workgroup. Toolkit: Providing Oncology Treatments in the Outpatient Setting. https://www.nccn.org/about/news/ ebulletin/pdf/NCCN%20OP%20Toolkit%20Final.pdf. [Accessed on August 13, 2020].
National Institute for Health and Care Excellence. Covid-19 rapid guideline: haematopoietic stem cell transplantation. NICE guideline [NG164]. April 2020. https://www.nice.org.uk/guidance/ng164. [Accessed on August 13, 2020].
Chen YM, Perng RP, Chu H, Tsai CM, Whang Peng J. Impact of severe acute respiratory syndrome on the status of lung cancer chemotherapy patients and a correlation of the signs and symptoms. Lung cancer. 2004; 45: 39-43.
https://www.uicc.org/news/addressing-challenges- cancer-community-raised-covid-19 24 June 2020. [Accessed on August 15, 2020].
CBC News. 14 cancer patients at Hamilton hospital saw doctor who tested positive for COVID-19. Available at https://www.cbc.ca/news/canada/hamilton/covid19-first-case-doctor-hamilton-healthsciences-1.5493530.
[Accessed on July, 28 2020].
Reis JC, Antoni MH, Travado L. Emotional distress, brain functioning, and bio behavioral processes in cancer patients: a neuroimaging review and future directions. CNS spectrums. 2020; 25: 79-100.
International Agency for Research on Cancer Globocan (2018) Pakistan fact sheet [https://gco.iarc.fr/today/data/ factsheets/populations/586-pakistan-fact-sheets] [Accessed on 2nd August 2020].
Yusuf A. Cancer care in the time of COVID-19—a perspective from Pakistan. Cancer medical science. 2020;14: 1026.
Ali I, Shah SA, Siddiqui N. Pakistan confirms first two cases of coronavirus, govt say “no need to panic”. DAWN. COM, February, 26. [Accessed on 3rd August 2020].
National institute of health (NIH) https://www.nih.org.pk/ novel-coranavirus-2019-ncov. [Accessed on 4th August 2020].
Centers for Disease Control and Prevention (CDC): Stress and Coping. Coronavirus Disease 2019 (COVID-19).
https://www. cdc.gov/coronavirus/2019-ncov/daily-life- coping/managingstress-anxiety. html. [Accessed on July 28th, 2020].
Raymond E, Thieblemont C, Alran S, Faivre S. Impact of the COVID-19 Outbreak on the Management of Patients with Cancer. Targeted Oncology. 2020; 15:249–59.
Al-Quteimat OM, Amer AM. The Impact of the COVID-19 Pandemic on Cancer Patients. Am J Clin Oncol. 2020; 43: 452-5.
Kutikov A, Weinberg DS, Edelman MJ, Horwitz EM, Uzzo RG, Fisher RI. A War on Two Fronts: Cancer Care in the Time of COVID-19. Ann Intern Med. 2020; 172: 756-8.
Ismaili N. COVID-19 Recommendations for Patients with Cancer: The post-COVID-19 Era. SN Comprehensive Clinical Medicine. 2020; 2: 1290-5.
Al-Shamsi, Humaid O, Alhazzani, Waleed, Alhuraiji, Ahmad, Coomes, Eric A, Chemaly, Roy F, Almuhanna, Meshari et al. A practical approach to the management of cancer patients during the novel coronavirus disease 2019 (COVID-19) pandemic: an international collaborative group. The oncologist. 2020; 25: 936.
